<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04339179</url>
  </required_header>
  <id_info>
    <org_study_id>INA107</org_study_id>
    <nct_id>NCT04339179</nct_id>
  </id_info>
  <brief_title>Observational Research on Infectious Disease Outbreaks and Difficult Cases of Unidentified Etiology in Indonesia</brief_title>
  <acronym>INA-ORCHID</acronym>
  <official_title>INA-RESPOND Observational Research on Infectious Disease Outbreaks and Difficult Cases of Unidentified Etiology in Indonesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ina-Respond</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ina-Respond</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This observational study will investigate suspected infectious diseases of unknown etiology
      prospectively during outbreaks and at healthcare facilities, and retrospectively through
      historical samples where no etiology was ever determined. The study is designed to rapidly,
      flexibly, and consistently respond to any potential scenario in Indonesia, and the data
      collected will provide needed insight into the landscape of infectious diseases in the
      country. By better understanding the infectious causes of outbreaks and difficult
      hospitalized cases, the Indonesian Ministry of Health will be able to more accurately and
      efficiently control infectious diseases and craft healthcare policies.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a study to identify the causative agents and describe the clinical characteristics of
      infectious disease outbreaks and difficult cases of unidentified etiology in Indonesia. It is
      a retrospective and prospective observational study with an exploratory design. There will be
      no intervention to the participants that is intended to affect their SoC or clinical outcome.

      Retrospective study activities will be ongoing throughout the duration of the study. The
      INA-RESPOND Reference Lab will perform research tests on various specimens collected as part
      of historical outbreaks and previous difficult cases where an etiology was never identified.

      Prospective study activities will be initiated upon official request from health authorities
      and health facilities/institutions. Requests are expected to be filtered through and
      evaluated by the 19 active INA-RESPOND Network sites before inclusion in the study. Samples
      collected during outbreaks and from difficult cases of unknown etiology will be analyzed at
      the INA-RESPOND Reference Lab at their own pace. Results from any research tests will be
      shared with the requesting authorities as research-use-only and are not intended to alter
      standard of care.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2025</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To identify the causative agents and describe the clinical characteristics of presumptive infections reported during infectious diseases outbreaks or referred from difficult cases of unidentified etiology in Indonesia.</measure>
    <time_frame>[Time Frame: 5 years] [No Safety Issue]</time_frame>
    <description>The etiologies (bacteria, viruses, parasites, fungi and others) of illness determined by Reference Laboratory tests expressed in percentages of enrolled subjects.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>To describe the disease course and case management of the presumptive infections</measure>
    <time_frame>[Time Frame: 5 years] [No Safety Issue]</time_frame>
    <description>Signs, symptoms, and clinical laboratory data from each confirmed diagnosis calculated in percentages.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To assess the accuracy of diagnostic tests of the presumptive infections</measure>
    <time_frame>[Time Frame: 5 years] [No Safety Issue]</time_frame>
    <description>The etiologies (bacteria, viruses, parasites, fungi and others) of illness determined by both point-of-care diagnostic tests and Reference Laboratory tests expressed as ratios.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To assess treatments and short-term outcomes of the presumptive infections</measure>
    <time_frame>[Time Frame: 5 years] [No Safety Issue]</time_frame>
    <description>Enrolled subject condition at end of study and duration of illness from enrollment to end of study.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To generate epidemiologic data to inform ongoing and future disease control and prevention efforts</measure>
    <time_frame>[Time Frame: 5 years] [No Safety Issue]</time_frame>
    <description>The etiologies (bacteria, viruses, parasites, fungi and others) of illness determined by Reference Laboratory tests expressed in percentages of enrolled subjects.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">2500</enrollment>
  <condition>Infectious Disease</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      whole blood, sputum, urine, stool, nasopharyngeal swab
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Adult or child of any age, both men and women hospitalized with a current episode of
        illness with a presumed infectious disease of unidentified etiology or referral from the
        MoH as part of a suspected or identified outbreak of infectious disease from 19 active
        INA-RESPOND Network sites across Indonesia
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Adult or child of any age hospitalized with a current episode of illness with a
             presumed infectious disease of unidentified etiology

          2. Negative for Dengue virus infection by an antigen-based and antibody-based diagnostic
             test (i.e. NS1 antigen test and Dengue-specific IgM test)

          3. Negative for Salmonella Typhi infection by Standard of Care testing (i.e. blood
             culture, Widal test, or Tubex rapid test)

          4. Able to provide a documented informed consent

          5. Agrees to the collection and storage of specimens for laboratory testing and/or future
             research (participants may decline storage of specimens for future research)

          6. For Ongoing patients in outbreak situations: Referral from the MoH as part of a
             suspected or identified outbreak of infectious disease

        Exclusion Criteria:

          -  Investigators' discretion for patient safety and well being
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dr. Muhammad Karyana, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Institute of Health Research and Development, Ministry of Health Republic of Indonesia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dr. Muhammad Karyana, MPH</last_name>
    <phone>+62 21 42879189</phone>
    <email>m.karyana@ina-respond.net</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>dr. Dona Arlinda, M.Sc.</last_name>
    <phone>+62 21 42879189</phone>
    <email>arlindona@ina-respond.net</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Site 520: University of Udayana/Sanglah Hospital</name>
      <address>
        <city>Denpasar</city>
        <state>Bali</state>
        <zip>80114</zip>
        <country>Indonesia</country>
      </address>
    </facility>
    <contact>
      <last_name>Prof. Dr. Ketut Tuti Merati, SpPD-KPTI</last_name>
      <phone>+62361246274</phone>
      <email>tutiparwati@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Dr. dr. Agus Somya Sp.PD (KPTI)</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Site 560: University of Diponegoro/ Dr. Kariadi Hospital</name>
      <address>
        <city>Semarang</city>
        <state>Central Of Java</state>
        <zip>50244</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site 530: University of Indonesia/ Dr. Cipto Mangunkusumo Hospital</name>
      <address>
        <city>Jakarta</city>
        <state>DKI Jakarta</state>
        <zip>10430</zip>
        <country>Indonesia</country>
      </address>
    </facility>
    <contact>
      <last_name>Prof. Dr. Pratiwi Sudarmono, PhD, SpMK (K)</last_name>
      <phone>+62 21 315 59 96</phone>
      <email>psdrmn@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Dr. dr. Evy Yunihastuti, Sp.PD-KAI</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Site 540: Penyakit Infeksi Sulianti Saroso Hospital</name>
      <address>
        <city>Jakarta</city>
        <state>DKI Jakarta</state>
        <zip>14340</zip>
        <country>Indonesia</country>
      </address>
    </facility>
    <contact>
      <last_name>Dr. Vivi Lisdawati, Msi,Apt</last_name>
      <phone>+62216506559</phone>
      <phone_ext>3119</phone_ext>
      <email>viandrashakti@yahoo.co.id</email>
    </contact>
    <investigator>
      <last_name>dr. Adria Rusli, Sp.P</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Site 590: Persahabatan Hospital</name>
      <address>
        <city>Jakarta</city>
        <state>DKI Jakarta</state>
        <zip>14340</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site 660 RSUD Abdul Wahab Sjahranie</name>
      <address>
        <city>Samarinda</city>
        <state>East Kalimantan</state>
        <zip>75123</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site 700 - RSUD Dr.TC Hillers</name>
      <address>
        <city>Maumere</city>
        <state>East Nusa Tenggara</state>
        <zip>86113</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site 570: University of Airlangga/ Dr. Soetomo Hospital</name>
      <address>
        <city>Surabaya</city>
        <state>East Of Java</state>
        <zip>60286</zip>
        <country>Indonesia</country>
      </address>
    </facility>
    <contact>
      <last_name>Prof. Dr.Usman Hadi SpPD-KPTI</last_name>
      <phone>+631 5035975</phone>
      <email>divtropin@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Prof. Dr.Usman Hadi SpPD, KPT</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Site 600 : Adam Malik Hospital</name>
      <address>
        <city>Medan</city>
        <state>North Sumatra</state>
        <zip>20136</zip>
        <country>Indonesia</country>
      </address>
    </facility>
    <contact>
      <last_name>dr. Bambang Prabowo, MARS</last_name>
      <phone>(+6261) 8360143</phone>
      <email>prabowob14@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>dr. Tambar Kembaren SpPD, K-PTI</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Site 690 - RSUD Abepura</name>
      <address>
        <city>Jayapura</city>
        <state>Papua</state>
        <zip>99351</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site 650: Budi Kemuliaan Hospital</name>
      <address>
        <city>Batam</city>
        <state>Riau Islands</state>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site 630: M. Ansari Saleh Hospital</name>
      <address>
        <city>Banjarmasin</city>
        <state>South Kalimantan</state>
        <zip>70125</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site 510: University of Padjajaran/ Dr. Hasan Sadikin Hospital</name>
      <address>
        <city>Bandung</city>
        <state>West Java</state>
        <zip>40161</zip>
        <country>Indonesia</country>
      </address>
    </facility>
    <contact>
      <last_name>dr. Bachti Alisjahbana, PhD, SpPD-KPTI</last_name>
      <phone>+62222030776</phone>
      <email>b.alisjahbana@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Dr. Rudi Wisaksana Sp.PD-KPTI.,Ph.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Site 610 : RSU Kabupaten Tangerang</name>
      <address>
        <city>Tangerang</city>
        <state>West Java</state>
        <zip>15111</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site 680 - RSUD dr Soedarso</name>
      <address>
        <city>Pontianak</city>
        <state>West Kalimantan</state>
        <zip>78111</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site 670 - RSUD Dr. Zainoel Abidin</name>
      <address>
        <city>Banda Aceh</city>
        <zip>24415</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site 640: St. Carolus Hospital</name>
      <address>
        <city>Jakarta</city>
        <zip>10440</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site 550: University of Hassanudin/ Dr. Wahidin Sudirohusodo Hospital</name>
      <address>
        <city>Makassar</city>
        <zip>90245</zip>
        <country>Indonesia</country>
      </address>
    </facility>
    <contact>
      <last_name>Prof. Dr. Mansyur Arif, PhD, SpPK (K)</last_name>
      <phone>+6411-582678</phone>
      <email>mansyur_arief@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>dr. Sudirman Katu SpPD, K-PTI</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Site 580: University of Gadjah Mada/ Dr. Sardjito Hospital</name>
      <address>
        <city>Yogyakarta</city>
        <zip>55284</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Indonesia</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>April 6, 2020</study_first_submitted>
  <study_first_submitted_qc>April 6, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 9, 2020</study_first_posted>
  <last_update_submitted>July 13, 2020</last_update_submitted>
  <last_update_submitted_qc>July 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Infectious Disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Infection</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

